Lessee, Operating Lease, Liability, to be Paid, Year Three of ESSA Pharma Inc. from 31 Dec 2023 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
ESSA Pharma Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Dec 2023 to 31 Mar 2025.
  • ESSA Pharma Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Mar 2025 was $46,193, a 66% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

ESSA Pharma Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $46,193 -$89,676 -66% 31 Mar 2025 10-Q 08 May 2025 2025 Q2
Q4 2024 $80,326 -$54,549 -40% 31 Dec 2024 10-Q 11 Feb 2025 2025 Q1
Q3 2024 $114,459 30 Sep 2024 10-K 17 Dec 2024 2024 FY
Q2 2024 $136,873 30 Jun 2024 10-Q 05 Aug 2024 2024 Q3
Q1 2024 $135,869 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 $134,875 31 Dec 2023 10-Q 13 Feb 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.